HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu-Ju Tseng Selected Research

chlorbenside

3/2021Plasminogen Activator Inhibitor-1 Secretion by Autophagy Contributes to Melanoma Resistance to Chemotherapy through Tumor Microenvironment Modulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu-Ju Tseng Research Topics

Disease

2Neoplasms (Cancer)
11/2021 - 03/2021
2Melanoma (Melanoma, Malignant)
11/2021 - 03/2021
1Olfactory Esthesioneuroblastoma (Esthesioneuroblastoma)
12/2022
1Hypertension (High Blood Pressure)
12/2022
1Posterior Leukoencephalopathy Syndrome
12/2022
1Balanitis
11/2022
1Carcinogenesis
03/2021
1Wounds and Injuries (Trauma)
01/2019
1Necrosis
01/2019
1Hematoma
01/2019
1Leukemia
02/2009

Drug/Important Bio-Agent (IBA)

2Plasminogen Activator Inhibitor 1IBA
11/2021 - 03/2021
1Endothelins (Endothelin)IBA
12/2022
1Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2022
1lenvatinibIBA
12/2022
1Methotrexate (Mexate)FDA LinkGeneric
11/2022
1tiplaxtininIBA
11/2021
1Immune Checkpoint InhibitorsIBA
11/2021
1Immune Checkpoint ProteinsIBA
11/2021
1LigandsIBA
11/2021
1Mitoxantrone (Novantrone)FDA LinkGeneric
03/2021
1Plasminogen Activators (Plasminogen Activator)IBA
03/2021
1chlorbensideIBA
03/2021
1platonin (NK 19)IBA
02/2009

Therapy/Procedure

3Therapeutics
12/2022 - 03/2021
1Immunotherapy
11/2021
1Drug Therapy (Chemotherapy)
03/2021
1Postoperative Care
01/2019